financetom
Business
financetom
/
Business
/
Scotiabank Previews Friday's Retail Sales, Producer Prices In Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scotiabank Previews Friday's Retail Sales, Producer Prices In Canada
Mar 20, 2026 5:28 AM

08:10 AM EDT, 03/20/2026 (MT Newswires) -- Canada will release retail sales for January and preliminary figures for February Friday at 8:30 a.m. ET, said Scotiabank.

Statistics Canada had previously guided back on Feb. 20 that January retail sales were estimated to be up by 1.5% month over month in nominal terms. Part of that gain is likely to be autos, noted the bank. Key will be volumes and breadth.

The other key will be the advance guidance StatsCan will provide for sales in February with no details, for which Scotiabank expects some moderation from the prior month.

That said, because of the way Q1 started with a strong gain in January, Canada could be looking at a solid quarter-over-quarter annualized gain in retail sales volumes that represent around 40% of consumer spending to help inform Q1 growth tracking, stated the bank. Tracking will be updated after the data.

Weather and a bad flu season might dampen the way the quarter ends, but that in turn could provide room for another math-driven gain in Q2.

Canada also updates February readings for industrial (IPPI) and raw materials (RMPI) prices at 8:30 a.m. ET, Friday. They've been on a sharp upswing of late, which informs debate over pass-through into consumer prices, given lagging historical correlations, added Scotiabank.

As a consequence, inflation risk remains pointed higher, according to the bank. It will pay particular attention to core industrial prices excluding energy that jumped 2.8% month over month in January.

This has been part of an upswing since the start of 2024 that is showing no signs of abating. Core industrial product prices have risen by about 15% since then.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blackstone, Lunate Form Partnership to Create Platform Targeting $5 Billion of Gulf Cooperation Council Warehouses
Blackstone, Lunate Form Partnership to Create Platform Targeting $5 Billion of Gulf Cooperation Council Warehouses
Oct 6, 2025
07:46 AM EDT, 10/06/2025 (MT Newswires) -- Blackstone (BX) and Lunate said Monday they have formed a partnership to establish a platform that will invest $5 billion in warehouse assets across the Gulf Cooperation Council region. The Gulf Logistics Infrastructure Development Enterprise platform will focus mainly on greenfield developments, complemented by selective portfolio acquisitions and sale-leaseback deals. The companies said...
Paris prosecutor's office probing Siri, Apple's voice assistant
Paris prosecutor's office probing Siri, Apple's voice assistant
Oct 6, 2025
PARIS (Reuters) -The Paris prosecutor's office said on Monday it was investigating Siri, Apple's ( AAPL ) voice assistant, after it received a complaint. Politico reported earlier on Monday that Apple ( AAPL ) is suspected of using users' recordings without their knowledge. ...
Collective Mining Announcing Agnico Eagle's Intention To Exercise Its Participation Rights In Offering
Collective Mining Announcing Agnico Eagle's Intention To Exercise Its Participation Rights In Offering
Oct 6, 2025
07:48 AM EDT, 10/06/2025 (MT Newswires) -- Collective Mining Ltd. ( CNL ) said Monday that, further to announcing last week a C$125 million 'bought deal' public offering of common shares led by a syndicate of underwriters, Agnico Eagle Mines Limited ( AEM ) has indicated to CNL that it intends to exercise its participation right to subscribe for 789,473...
Skye Bioscience Phase 2 Trial of Weight Loss Drug Nimacimab Misses Primary Endpoint; Shares Plunge Pre-Bell
Skye Bioscience Phase 2 Trial of Weight Loss Drug Nimacimab Misses Primary Endpoint; Shares Plunge Pre-Bell
Oct 6, 2025
07:47 AM EDT, 10/06/2025 (MT Newswires) -- Skye Bioscience ( SKYE ) shares plummeted more than 58% in recent premarket activity after it said Monday that its phase 2a trial of nimacimab to treat patients with obesity missed its primary endpoint of weight loss compared with placebo. The company said its preliminary analysis found that the 200 mg, subcutaneous weekly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved